OBJECTIVE: Hysterectomy, with or without oophorectomy, is associated with increased cardiovascular disease (CVD) risk due, in part, to an adverse CVD risk factor profile. Large artery stiffening, a biomarker of vascular aging, increases the risk for CVD. We determined whether hysterectomy with or without bilateral oophorectomy (BLO) is associated with arterial stiffening in healthy postmenopausal women. METHODS: We conducted a cross-sectional study including estrogen-deficient postmenopausal women who had a hysterectomy with ovarian preservation (n = 24; mean ± SE age, 59 ± 1 y) or with BLO (n = 21; 58 ± 2 y) and had no hysterectomy/no BLO (n = 58; 58 ± 1 y). Arterial stiffness (arterial compliance and β stiffness index) was measured by ultrasonography of the carotid artery. RESULTS: Carotid artery compliance was lower in women with hysterectomy alone and in women with hysterectomy with BLO compared with women with no hysterectomy (0.66 ± 0.03 and 0.71 ± 0.06 vs 0.89 ± 0.03 mm/mm Hg × 10, respectively, both P < 0.05). There were no differences in traditional CVD risk factors (ie, adiposity, blood pressure and fasted lipids and lipoproteins, glucose, and insulin) between the groups. After adjustment for age, menopause duration, previous menopausal hormone therapy duration, parity, waist-to-hip ratio, systolic blood pressure, and sex hormone-binding globulin, hysterectomy status remained a significant predictor of arterial compliance. CONCLUSIONS: These results indicate that hysterectomy status (with or without BLO) is associated with greater arterial stiffening in estrogen-deficient postmenopausal women. The greater arterial stiffening with hysterectomy was not related to an adverse CVD risk profile. Large artery stiffening may be an important mechanism by which hysterectomy increases the risk of CVD in postmenopausal women.
OBJECTIVE: Hysterectomy, with or without oophorectomy, is associated with increased cardiovascular disease (CVD) risk due, in part, to an adverse CVD risk factor profile. Large artery stiffening, a biomarker of vascular aging, increases the risk for CVD. We determined whether hysterectomy with or without bilateral oophorectomy (BLO) is associated with arterial stiffening in healthy postmenopausal women. METHODS: We conducted a cross-sectional study including estrogen-deficient postmenopausal women who had a hysterectomy with ovarian preservation (n = 24; mean ± SE age, 59 ± 1 y) or with BLO (n = 21; 58 ± 2 y) and had no hysterectomy/no BLO (n = 58; 58 ± 1 y). Arterial stiffness (arterial compliance and β stiffness index) was measured by ultrasonography of the carotid artery. RESULTS: Carotid artery compliance was lower in women with hysterectomy alone and in women with hysterectomy with BLO compared with women with no hysterectomy (0.66 ± 0.03 and 0.71 ± 0.06 vs 0.89 ± 0.03 mm/mm Hg × 10, respectively, both P < 0.05). There were no differences in traditional CVD risk factors (ie, adiposity, blood pressure and fasted lipids and lipoproteins, glucose, and insulin) between the groups. After adjustment for age, menopause duration, previous menopausal hormone therapy duration, parity, waist-to-hip ratio, systolic blood pressure, and sex hormone-binding globulin, hysterectomy status remained a significant predictor of arterial compliance. CONCLUSIONS: These results indicate that hysterectomy status (with or without BLO) is associated with greater arterial stiffening in estrogen-deficient postmenopausal women. The greater arterial stiffening with hysterectomy was not related to an adverse CVD risk profile. Large artery stiffening may be an important mechanism by which hysterectomy increases the risk of CVD in postmenopausal women.
Authors: Frances M Stewart; Dilys J Freeman; Jane E Ramsay; Ian A Greer; Muriel Caslake; William R Ferrell Journal: J Clin Endocrinol Metab Date: 2006-12-27 Impact factor: 5.958
Authors: Kim Sutton-Tyrrell; Rachel P Wildman; Karen A Matthews; Claudia Chae; Bill L Lasley; Sarah Brockwell; Richard C Pasternak; Donald Lloyd-Jones; Mary Fran Sowers; Javier I Torréns Journal: Circulation Date: 2005-03-15 Impact factor: 29.690
Authors: Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick Journal: JAMA Date: 2007-04-04 Impact factor: 56.272
Authors: Nisha I Parikh; Sven Cnattingius; Paul W Dickman; Murray A Mittleman; Jonas F Ludvigsson; Erik Ingelsson Journal: Am Heart J Date: 2010-02 Impact factor: 4.749
Authors: Maura K Whiteman; Susan D Hillis; Denise J Jamieson; Brian Morrow; Michelle N Podgornik; Kate M Brett; Polly A Marchbanks Journal: Am J Obstet Gynecol Date: 2007-11-05 Impact factor: 8.661
Authors: Matthew A Allison; Joann E Manson; Robert D Langer; J Jeffrey Carr; Jacques E Rossouw; Mary B Pettinger; Lawrence Phillips; Barbara B Cochrane; Charles B Eaton; Philip Greenland; Susan Hendrix; Judith Hsia; Julie R Hunt; Rebecca D Jackson; Karen C Johnson; Lewis H Kuller; Jennifer Robinson Journal: Menopause Date: 2008 Jul-Aug Impact factor: 2.953
Authors: William H Parker; Michael S Broder; Eunice Chang; Diane Feskanich; Cindy Farquhar; Zhimae Liu; Donna Shoupe; Jonathan S Berek; Susan Hankinson; JoAnn E Manson Journal: Obstet Gynecol Date: 2009-05 Impact factor: 7.661
Authors: Charlotte W Usselman; Chantelle A Nielson; Torri A Luchyshyn; Tamara I Gimon; Nicole S Coverdale; Stan H M Van Uum; J Kevin Shoemaker Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-10-12 Impact factor: 3.619
Authors: Shannon K Laughlin-Tommaso; Zaraq Khan; Amy L Weaver; Carin Y Smith; Walter A Rocca; Elizabeth A Stewart Journal: Menopause Date: 2018-05 Impact factor: 2.953
Authors: Benard O Ogola; Margaret A Zimmerman; Gabrielle L Clark; Caleb M Abshire; Kaylee M Gentry; Kristin S Miller; Sarah H Lindsey Journal: Am J Physiol Heart Circ Physiol Date: 2018-07-20 Impact factor: 4.733
Authors: Kerrie L Moreau; Kerry L Hildreth; Amie L Meditz; Kevin D Deane; Wendy M Kohrt Journal: J Clin Endocrinol Metab Date: 2012-09-11 Impact factor: 5.958